Aarti Pharmalabs Ltd. Financials: Quarterly Results
Revenue
431.9
Cr.
PAT
43.03
Cr.
EBITDA
73.32
Cr.
Aarti Pharmalabs Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 432.27 | 418.33 | 386.19 | 563.78 | 537.78 |
| Total Income From Operations (Cr.) | 432.27 | 418.33 | 386.19 | 563.78 | 537.78 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 73.32 | 50 | 74.05 | 121.20 | 110.60 |
| P/L Before Exceptional Items & Tax (Cr.) | 60.74 | 39.33 | 67.25 | 114.62 | 100.63 |
| P/L After Tax from Ordinary Activities (Cr.) | 43.03 | 28.57 | 51.30 | 88.34 | 73.99 |
| Net Profit/Loss For the Period (Cr.) | 43.03 | 28.57 | 51.30 | 88.34 | 73.99 |
| Basic EPS | 5.29 | 3.08 | 5.46 | 9.75 | 8.16 |
FAQs
Aarti Pharmalabs Ltd. announced its quarterly results for Q3 FY2026 on February 10, 2026.
In Q3 FY2026, Aarti Pharmalabs Ltd. are as follows:
Revenue: ₹431.9 crore
Net Profit: ₹43.03 crore.
For Q3 FY2026, Aarti Pharmalabs Ltd. posted ₹431.9 crore in revenue and ₹43.03 crore in net profit.
Past quarterly results for Aarti Pharmalabs Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.